I

Immuno Cancer Biotherapeutics

Biotechnology

Legal name: Immuno Cancer Biotherapeutics, Inc. · Corporation

Canton, SD
Explore comparable companies and investor patterns →My company watchlist
$75K
Total Raised
1
Form D filings
Oct 2026
First Raise
Oct 2026
Last Raise

From SEC Form D filings. Amounts are totals sold as reported by the company, in USD.

Funding Timeline

Reg D offeringOct 9, 2026
$75K raisedOffering size: Indefinite3 investors
Securities: other
SEC filing File 021-601448

People

Executive officers, directors and promoters named on the company's SEC Form D filings.

J
James Robl

Director · Executive Officer

Listed Oct 2026Form D
S
Stephen Collins

Director

Listed Oct 2026Form D

Sources

  • SEC Form D
  • SEC CIK2158173